H. Kurata

604 total citations
20 papers, 456 citations indexed

About

H. Kurata is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, H. Kurata has authored 20 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in H. Kurata's work include Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (5 papers) and Ion channel regulation and function (4 papers). H. Kurata is often cited by papers focused on Sphingolipid Metabolism and Signaling (11 papers), Lipid Membrane Structure and Behavior (5 papers) and Ion channel regulation and function (4 papers). H. Kurata collaborates with scholars based in Japan, United States and China. H. Kurata's co-authors include Hirotaka Mizuno, Shinji Nakade, Hiroshi Hagiya, Gye Won Han, C. Roth, Raymond C. Stevens, Jill Chrencik, Caroline Rodgers, Mark T. Griffith and R. Omi and has published in prestigious journals such as Cell, PLoS ONE and Chemical Communications.

In The Last Decade

H. Kurata

20 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Kurata Japan 12 370 82 63 61 52 20 456
Elina Ekokoski Finland 15 382 1.0× 84 1.0× 56 0.9× 40 0.7× 35 0.7× 29 540
Ulla Näpänkangas Sweden 8 290 0.8× 64 0.8× 74 1.2× 34 0.6× 40 0.8× 11 451
Michael McClurg United States 6 503 1.4× 85 1.0× 30 0.5× 41 0.7× 65 1.3× 9 597
Emmanouil Zacharioudakis United States 8 355 1.0× 72 0.9× 26 0.4× 47 0.8× 27 0.5× 14 510
Jianjun Xu Japan 13 340 0.9× 151 1.8× 46 0.7× 35 0.6× 89 1.7× 27 540
Marta Calbet Spain 14 210 0.6× 88 1.1× 41 0.7× 56 0.9× 53 1.0× 23 461
Paul Taslimi United States 8 392 1.1× 38 0.5× 69 1.1× 73 1.2× 19 0.4× 9 498
Philipp Lampe Germany 10 553 1.5× 45 0.5× 74 1.2× 29 0.5× 30 0.6× 18 651
D. McAndrew Australia 2 454 1.2× 136 1.7× 57 0.9× 18 0.3× 43 0.8× 3 739

Countries citing papers authored by H. Kurata

Since Specialization
Citations

This map shows the geographic impact of H. Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kurata more than expected).

Fields of papers citing papers by H. Kurata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kurata. The network helps show where H. Kurata may publish in the future.

Co-authorship network of co-authors of H. Kurata

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kurata. A scholar is included among the top collaborators of H. Kurata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kurata. H. Kurata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urata, H, Masaya Kokubo, Takahiro Mori, et al.. (2025). Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator In Vivo Tool Compound. ACS Chemical Neuroscience. 16(5). 960–967. 1 indexed citations
2.
Tanaka, Motoyuki, Takahiro Mori, Gakuji Hashimoto, et al.. (2025). Discovery of ONO-TR-772 (VU6018042): A Highly Selective and CNS Penetrant TREK Inhibitor in Vivo Tool Compound. ACS Medicinal Chemistry Letters. 16(5). 896–901. 1 indexed citations
3.
Kharade, Sujay V., H. Kurata, Aaron M. Bender, et al.. (2018). Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992. Molecular Pharmacology. 94(2). 926–937. 45 indexed citations
5.
Swale, Daniel R., H. Kurata, Sujay V. Kharade, et al.. (2016). ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels. ACS Chemical Neuroscience. 7(7). 1013–1023. 26 indexed citations
6.
Shinozaki, Koji, Yoshiyuki Yamaura, H. Kurata, et al.. (2016). Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives. Bioorganic & Medicinal Chemistry Letters. 26(4). 1209–1213. 18 indexed citations
7.
Chrencik, Jill, C. Roth, H. Kurata, et al.. (2015). Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 161(7). 1633–1643. 147 indexed citations
8.
Shinozaki, Koji, Yoshiyuki Yamaura, H. Kurata, et al.. (2015). Discovery of novel S1P2 antagonists. Part 2: Improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives. Bioorganic & Medicinal Chemistry Letters. 25(20). 4387–4392. 15 indexed citations
9.
Shinozaki, Koji, Toshiya Kanaji, H. Kurata, et al.. (2015). Discovery of novel S1P2 antagonists. Part 1: Discovery of 1,3-bis(aryloxy)benzene derivatives. Bioorganic & Medicinal Chemistry Letters. 25(7). 1479–1482. 17 indexed citations
10.
Kurata, H., Patrick R. Gentry, Masaya Kokubo, et al.. (2014). Further optimization of the M5 NAM MLPCN probe ML375: Tactics and challenges. Bioorganic & Medicinal Chemistry Letters. 25(3). 690–694. 17 indexed citations
11.
Hagiya, Hiroshi, H. Kurata, M Kurono, et al.. (2012). Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis. Clinical & Experimental Immunology. 171(1). 54–62. 41 indexed citations
12.
Mizushima, Tsunekazu, Yasuyuki Kai, Junichi Nishimura, et al.. (2011). Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis. PLoS ONE. 6(9). e23933–e23933. 48 indexed citations
13.
Kurata, H., Ryo Suzuki, M Kurono, et al.. (2011). Structure–activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. Bioorganic & Medicinal Chemistry Letters. 22(1). 144–148. 14 indexed citations
14.
Kurata, H., Ryo Suzuki, M Kurono, et al.. (2011). Discovery of S1P agonists with a dihydronaphthalene scaffold. Bioorganic & Medicinal Chemistry Letters. 21(13). 3885–3889. 7 indexed citations
15.
Kurata, H., M Kurono, Takuya Seko, et al.. (2011). Structure–activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-β-alanine moiety. Bioorganic & Medicinal Chemistry Letters. 21(5). 1390–1393. 7 indexed citations
16.
Song, Jinghai, Hiroshi Hagiya, H. Kurata, Hirotaka Mizuno, & Toshinori Ito. (2011). Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation. Transplant Immunology. 26(2-3). 163–170. 10 indexed citations
17.
Matano, Yoshihiro, et al.. (1998). Water-soluble non-ionic triarylbismuthanes. First synthesis and properties. Journal of the Chemical Society Perkin Transactions 1. 2511–2518. 5 indexed citations
18.
Matano, Yoshihiro, H. Kurata, Toshihiro Murafuji, Nagao Azuma, & Hitomi Suzuki. (1998). Synthesis and Properties of a Series of Phenylene-Bridged Bin-Bismuthanes. Organometallics. 17(18). 4049–4059. 11 indexed citations
19.
Suzuki, Hitomi, H. Kurata, & Yoshihiro Matano. (1997). First synthesis and properties of dendritic Bin-bismuthanes. Chemical Communications. 2295–2296. 9 indexed citations
20.
Yoshikawa, Katsunori, et al.. (1978). Mutagenicity of benzene derivatives in Salmonella typhimurium. Mutation Research/Environmental Mutagenesis and Related Subjects. 54(2). 262–263. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026